a leap forward, page-6

Al - the article is a great find and more than coincidental timing.

It not only underpins DS potential as a ROW partner, but it also completes that all important BARDA piece of the puzzle requirement.

If I was a bookmaker, the BTA-DS ROW odds would have shortened dramatically after reading this article.

DS will ultimately get a nice slice of the action and Biota might end up with a clear 20% royalties if they play their cards right.

Here is part of the text for those who didn't go to the link.

February 15, 2011, Parsippany, NJ ? Daiichi Sankyo, Inc. (DSI), today announced the acquisition of a 140,000 square foot facility in Bethlehem Township, Pennsylvania from Amcor, a global packaging manufacturer. This acquisition, worth $10.25 million, enables DSI to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility. The facility is expected to be operational in the summer or early fall of 2011 and is expected to package some of the company?s portfolio of marketed products, such as Benicar?, Welchol? and Azor?. Once the facility is operating at full capacity, it is expected to assume an increasing responsibility for packaging the entire line of marketed products in the U.S., as well as perform compounding operations for select products.